Archives
-
Gepotidacin: From Target Assay to Clinical Signal
2026-08-24
Gepotidacin, also known as GSK2140944, connects a distinctive bacterial topoisomerase mechanism with clinically meaningful urinary tract infection data. This guide shows how to translate biochemical, susceptibility, resistance, and pharmacokinetic evidence into better antibacterial research decisions.
-
Phosphotungstic Acid Negative Stain Solution Guide
2026-08-24
Turn ready-to-use negative staining into a reproducible workflow for virus imaging, macromolecule analysis, and particle-quality control. This guide connects conserved coronavirus glycan research with practical electron microscopy preparation, interpretation limits, and troubleshooting.
-
Dihydroethidium (DHE): Superoxide Assay Guide
2026-08-23
Dihydroethidium, also called hydroethidine, is a cell-permeable fluorescent probe for relative intracellular superoxide measurement. Its red signal is useful in oxidative stress assays, but reliable interpretation requires separating superoxide-derived 2-hydroxyethidium from nonspecific ethidium formation.
-
Trelagliptin and PI-3K/AKT Signaling in Adipocytes
2026-08-22
The reference study examines how trelagliptin succinate, a long-acting DPP-4 inhibitor, affects insulin resistance in differentiated 3T3-L1 adipocytes. Its central finding is that trelagliptin enhances IRS-1/AKT signaling, promotes membrane-associated GLUT4 and glucose intake, and reduces free fatty acid and resistin secretion, providing a cellular mechanism beyond its established glucose-lowering activity.
-
DDM for Membrane Protein Cryo-EM Workflows
2026-08-22
n-Dodecyl-β-D-maltoside helps solubilize difficult membrane proteins while preserving the assemblies needed for purification, activity testing, and cryo-EM. This workflow-focused guide shows how to screen DDM, manage detergent exchange, and troubleshoot aggregation, inactivity, and grid-quality problems.
-
Fenipentol: An Evidence-Gated Research Strategy
2026-08-21
Fenipentol and 1-Phenyl-1-pentanol are useful starting points for linking secretory physiology with receptor and metabolism research. This evidence-gated guide separates compound identity from isomeric literature, translates historical choleretic observations into assay decisions, and defines responsible hepatic research extensions.
-
Tropisetron Hydrochloride: Assay Workflows
2026-08-20
Build receptor and renal transporter assays around Tropisetron Hydrochloride, using its 5-HT3 activity to interrogate serotonin biology and its transporter effects to model drug–drug interaction risk. The workflow combines concentration-aware pharmacology, polarized cell transport, and practical troubleshooting for reproducible research.
-
Erastin as a Redox-Threshold Probe for Ferroptosis
2026-08-20
Erastin is a ferroptosis inducer that reveals how cystine, glutathione, iron, and lipid oxidation interact to determine cell fate. This guide connects tumor-cell assays with findings from aging lens epithelium to improve experimental interpretation and model selection.
-
MK-8745 Aurora A Inhibitor for Cell Assays
2026-08-19
A scenario-based guide to using MK-8745, Aurora A inhibitor, potent and selective (SKU A8807) in cell viability, proliferation, cell-cycle, and apoptosis workflows. It connects assay design, formulation, interpretation, and model selection to product-documented quantitative parameters and relevant Aurora A literature.
-
OCT2 and MATE1 Inhibition by Antiemetic Drugs
2026-08-19
George and colleagues evaluated how five 5-HT3 receptor antagonist drugs interfere with the renal organic cation transporters OCT2 and MATE1. Their cell-based results identify compound-specific inhibition profiles and show why transporter-mediated drug interactions should be considered when studying antiemetic pharmacology and cationic drug clearance.
-
From Pheromone Signals to Precision PCR
2026-08-18
Translational neurogenetics increasingly depends on connecting environmental cues, developmental signaling, and adult neurodegeneration to precise sequence-level evidence. This thought-leadership article examines how the C. elegans pheromone study reframes experimental priorities and why a proofreading DNA polymerase, particularly HyperFusion™ high-fidelity DNA polymerase, can strengthen validation across GC-rich, long, and inhibitor-laden templates.
-
5-hme-dCTP: A Smarter 5hmC Assay Framework
2026-08-18
5-hme-dCTP enables controlled studies of hydroxymethylated DNA and DNA polymerase behavior. This guide focuses on assay interpretation, controls, and how rice drought-response evidence should shape experimental design.
-
QNZ (EVP4593): NF-κB Pathway Research Guide
2026-08-17
QNZ, also known as EVP4593, is a quinazoline derivative used for NF-κB signaling pathway modulation. Product data report nanomolar activity in Jurkat T-cell reporter assays and research utility in inflammation and Huntington’s disease models, while emphasizing assay-specific interpretation and careful solvent handling.
-
SM-164 Workflow for Apoptosis Assays
2026-08-17
SM-164 provides a practical way to connect rapid IAP engagement with TNFα-dependent apoptosis and downstream caspase activity in tumor-cell models. This workflow combines target-degradation kinetics, orthogonal cell-death measurements, and troubleshooting guidance for reproducible cancer research assays.
-
Cy7 NHS Ester: Practical Labeling Protocol
2026-08-16
Cy7 NHS ester (SKU A8109) provides a water-soluble near-infrared dye for bioimaging of proteins and peptides through amino-group labeling. It is suited to aqueous biomolecule conjugation and imaging workflows, but reaction conditions, labeling density, live-cell compatibility, and in vivo performance should be validated for each target rather than inferred from product specifications.